Gene · 17
Papers1,442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,442
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of CD133+ intercellsomes in intercellular communication to offset intracellular signal deficit. | Elife | 2023 | 37846866 | PubTator, text mining | PubMed |
| Genome-wide analysis of the interplay between chromatin-associated RNA and 3D genome organization in human cells. | Nat Commun | 2023 | 37845234 | PubTator, text mining | PubMed |
Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-boxFBXO11 -mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma. | Clin Transl Med | 2023 | 37837399 | PubTator, text mining | PubMed |
| Design and testing of a humanized porcine donor for xenotransplantation. | Nature | 2023 | 37821590 | PubTator, text mining | PubMed |
| In vivo recording of the circadian calcium rhythm in Prokineticin 2 neurons of the suprachiasmatic nucleus. | Sci Rep | 2023 | 37813987 | PubTator, text mining | PubMed |
| Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management. | Int J Nanomedicine | 2023 | 37795042 | PubTator, text mining | PubMed |
| Massively parallel in vivo Perturb-seq reveals cell type-specific transcriptional networks in cortical development. | bioRxiv | 2023 | 37790302 | PubTator, text mining | PubMed |
| Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium. | Mol Ther Methods Clin Dev | 2023 | 37790246 | PubTator, text mining | PubMed |
| A CRISPR Screen of HIV Dependency Factors Reveals That CCNT1 Is Non-Essential in T Cells but Required for HIV-1 Reactivation from Latency. | Viruses | 2023 | 37766271 | PubTator, text mining | PubMed |
| Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape. | Int J Mol Sci | 2023 | 37762045 | PubTator, text mining | PubMed |
| Assembloid CRISPR screens reveal impact of disease genes in human neurodevelopment. | Nature | 2023 | 37758944 | PubTator, text mining | PubMed |
| Gene regulatory network inference from CRISPR perturbations in primary CD4+ T cells elucidates the genomic basis of immune disease. | bioRxiv | 2023 | 37745614 | PubTator, text mining | PubMed |
| In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging. | Front Cardiovasc Med | 2023 | 37745108 | PubTator, text mining | PubMed |
| Optogenetic induction of alpha-synuclein aggregation in human dopaminergic neurons to model Parkinson's disease pathology. | STAR Protoc | 2023 | 37742181 | PubTator, text mining | PubMed |
| Defining E3 ligase-substrate relationships through multiplex CRISPR screening. | Nat Cell Biol | 2023 | 37735597 | PubTator, text mining | PubMed |
| Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys. | Signal Transduct Target Ther | 2023 | 37735155 | PubTator, text mining | PubMed |
| The Fanconi anemia core complex promotes CtIP-dependent end-resection to drive homologous recombination at DNA double-strand breaks. | bioRxiv | 2023 | 37732274 | PubTator, text mining | PubMed |
| ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia. | Nat Commun | 2023 | 37726279 | PubTator, text mining | PubMed |
| Gene therapy using genome-edited iPS cells for targeting malignant glioma. | Bioeng Transl Med | 2023 | 37693056 | PubTator, text mining | PubMed |
| DUX4 expression in cancer induces a metastable early embryonic totipotent program. | Cell Rep | 2023 | 37691147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/17/papers?page=6